These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25081293)

  • 1. Treating maculopathy at the expense of proliferative disease: an emerging problem in 'macular treatment centres'.
    Mookhtiar MA; Carrim ZI
    Eye (Lond); 2014 Nov; 28(11):1390-1. PubMed ID: 25081293
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement of diabetic retinopathy with intravitreal Ranibizumab.
    Kernt M; Cserhati S; Seidensticker F; Liegl R; Kampik A; Neubauer A; Ulbig MW; Reznicek L
    Diabetes Res Clin Pract; 2013 Apr; 100(1):e11-3. PubMed ID: 23391744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of panretinal photocoagulation with and without intravitreal ranibizumab in treatment-naive eyes with non-high-risk proliferative diabetic retinopathy.
    Ferraz DA; Vasquez LM; Preti RC; Motta A; Sophie R; Bittencourt MG; Sepah YJ; Monteiro ML; Nguyen QD; Takahashi WY
    Retina; 2015 Feb; 35(2):280-7. PubMed ID: 25272318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution of diabetic papillopathy after a single intravitreal injection of ranibizumab.
    Willerslev A; Munch IC; Larsen M
    Acta Ophthalmol; 2012 Aug; 90(5):e407-9. PubMed ID: 22268957
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravitreal ranibizumab for diabetic macular oedema: 1-year experiences in a clinical setting.
    Brynskov T; Laugesen CS; Sørensen TL
    Acta Ophthalmol; 2013 May; 91(3):e243-4. PubMed ID: 23280048
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy.
    Ip MS; Domalpally A; Sun JK; Ehrlich JS
    Ophthalmology; 2015 Feb; 122(2):367-74. PubMed ID: 25439595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
    Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
    Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trial.
    Mitchell P; Bressler N; Tolley K; Gallagher M; Petrillo J; Ferreira A; Wood R; Bandello F;
    JAMA Ophthalmol; 2013 Oct; 131(10):1339-47. PubMed ID: 23974915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment.
    Do DV; Nguyen QD; Khwaja AA; Channa R; Sepah YJ; Sophie R; Hafiz G; Campochiaro PA;
    JAMA Ophthalmol; 2013 Feb; 131(2):139-45. PubMed ID: 23544200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study.
    Schmidt-Erfurth U; Lang GE; Holz FG; Schlingemann RO; Lanzetta P; Massin P; Gerstner O; Bouazza AS; Shen H; Osborne A; Mitchell P;
    Ophthalmology; 2014 May; 121(5):1045-53. PubMed ID: 24491642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of macular ischemia on intravitreal ranibizumab treatment for diabetic macular edema.
    Douvali M; Chatziralli IP; Theodossiadis PG; Chatzistefanou KI; Giannakaki E; Rouvas AA
    Ophthalmologica; 2014; 232(3):136-43. PubMed ID: 25171753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial.
    Bressler SB; Qin H; Melia M; Bressler NM; Beck RW; Chan CK; Grover S; Miller DG;
    JAMA Ophthalmol; 2013 Aug; 131(8):1033-40. PubMed ID: 23807371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment.
    Bressler SB; Almukhtar T; Bhorade A; Bressler NM; Glassman AR; Huang SS; Jampol LM; Kim JE; Melia M;
    JAMA Ophthalmol; 2015 May; 133(5):589-97. PubMed ID: 25719991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy.
    Gross JG; Glassman AR; Klein MJ; Jampol LM; Ferris FL; Bressler NM; Beck RW
    JAMA Ophthalmol; 2017 Jun; 135(6):672-673. PubMed ID: 28492921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing aflibercept, bevacizumab, and ranibizumab for DME: analysis of DRCR Protocol T.
    Wykoff CC; Hariprasad SM
    Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):302-5. PubMed ID: 25835307
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE phase III clinical trials.
    Domalpally A; Ip MS; Ehrlich JS
    Ophthalmology; 2015 Apr; 122(4):779-86. PubMed ID: 25601535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Treatment for Proliferative Diabetic Retinopathy: Anti-Vascular Endothelial Growth Factor Therapy.
    Gross JG; Glassman AR
    JAMA Ophthalmol; 2016 Jan; 134(1):13-4. PubMed ID: 26583372
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab.
    Bressler SB; Qin H; Beck RW; Chalam KV; Kim JE; Melia M; Wells JA;
    Arch Ophthalmol; 2012 Sep; 130(9):1153-61. PubMed ID: 22965591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.
    Mitchell P; Bandello F; Schmidt-Erfurth U; Lang GE; Massin P; Schlingemann RO; Sutter F; Simader C; Burian G; Gerstner O; Weichselberger A;
    Ophthalmology; 2011 Apr; 118(4):615-25. PubMed ID: 21459215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy for diabetic macular edema.
    Al Rashaed S; Arevalo JF
    Middle East Afr J Ophthalmol; 2013; 20(4):315-20. PubMed ID: 24339681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.